Ann: March 2018 Investor Presentation, page-45

I have a feeling that this will keep going...I think there is a clearing of a backlog of holders that have been waiting for the opportunity to get out.
With the results of the breast trial imminent...I think the market is anticipating good results.It is the achievement of market milestones..ie positive data that sends the SP higher...as it mitigates and derisks the future trials.
It has a further positive effect on all our other trials in progress we are working with the same molecule PTX 200 in different ways.
It also derisks the safety question that the market is wary of...good results in the breast cancer trial ie greater than 25% is very exciting for PTX.
So lets wait and see.